Resistance of Beta 2 Microglobulin Null Mice to Sepsis
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
批准号:
8292209
负责人:
EDWARD R SHERWOOD
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2012-07-02
关键词:
AddressAnimalsCXCL10 geneCXCL9 geneCXCR3 geneCell physiologyCellsCritical IllnessDisease modelEvaluationExperimental ModelsFunctional disorderFundingGreater sac of peritoneumInfectionInflammationInflammatoryInjuryKnockout MiceKnowledgeLeftLigandsLigationLiquid substanceMediatingModelingMorbidity - disease rateMusNK Cell ActivationNatural Killer CellsOrganOutcomePathogenesisPathway interactionsPatientsPeritoneal lavagePhysiologicalPlasmaPopulationProductionPuncture procedureResearchResistanceSepsisSepsis SyndromeSeptic ShockSignal TransductionSiteSourceSpleenTestingTissuesautocrinebasebeta-2 Microglobulincell motilitychemokine receptorimprovedinnovationmacrophagemortalityneutralizing antibodyparacrineseptic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have convincingly shown that natural killer (NK) cells facilitate the pathogenesis of sepsis caused
by cecal ligation and puncture (CLP). However, the mechanisms that contribute to NK cell-mediated
pro-inflammatory activity during sepsis are poorly understood. Our recent studies indicate large
numbers of CXCR3+ NK cells leave the spleen and enter the peritoneal cavity during CLP-induced
sepsis. The CXCR3 ligands CXCL9 and CXCL10 are present at high concentrations during sepsis and
CXCR3-deficient mice are resistant to CLP-induced physiologic dysfunction. Based on these
observations, we hypothesize that CXCR3 signaling is critical for the recruitment and activation
of NK cells and that the actions of CXCR3 are important in the pathogenesis of sepsis. The
following specific aims will test these hypotheses. Specific Aim 1: To determine the importance of
CXCR3 for NK cell migration and activation as well as its impact on the pathogenesis of CLP-
induced sepsis. The expression of CXCR3 and markers of activation will be evaluated on NK cells at
the primary site of infection and in remote tissues. Further studies will assess NK cell recruitment and
activation in CXCR3-deficient mice and after blockade of CXCR3 with neutralizing antibodies. We will
also determine the importance of CXCR3 in the pathogenesis of sublethal sepsis, sepsis-induced multi-
organ dysfunction and septic shock. Specific Aim 2. To determine the importance of CXCR3
ligands (CXCL9 and CXCL10) for NK cell recruitment and activation as well as their impact on
the pathogenesis of CLP-induced sepsis. The cellular sources of CXCR3 ligands at the primary site
of infection and remote tissues will be examined. NK cell migration and activation will be studied in
CXCR3 ligand-deficient mice or after blockade of CXCR3 ligands using neutralizing antibodies.
Physiological function, organ injury and systemic inflammation will be examined in CXCR3 ligand-
deficient mice using models of sublethal sepsis, sepsis-induced multi-organ dysfunction and septic
shock. We will also determine the ability of CXCR3 ligands to directly induce the sepsis syndrome in
control mice or mice with sublethal sepsis. Specific aim 3. Evaluation of factors that regulate the
CXCR3 axis during CLP-induced sepsis. These studies will examine the contributions of NK cells to
CXCR3 ligand production and the factors that regulate NK cell CXCR3 expression during sepsis.
Although LPS-induced CXCL10 production by isolated macrophages is considered to be regulated by
Trif-dependent signaling and require production of IFN¿, we propose that NK cells will facilitate MyD88-
dependent CXCL10 production through the production of IFN¿. Studies are proposed in this application
to address that assertion. Further studies will evaluate the importance of paracrine and autocrine
mechanisms for NK cell CXCR3 activation and the factors that regulate CXCR3 expression by NK cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Macrophage mitochodrial reprogramming and innate immune memory
-
批准号:10550138
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2020
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Macrophage mitochodrial reprogramming and innate immune memory
-
批准号:10333362
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2020
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Training Innate Immunity: A new approach to the treatment of Sepsis
-
批准号:10296894
-
项目类别:
-
资助金额:$55.35万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Training Innate Immunity: A new approach to the treatment of Sepsis
-
批准号:10461115
-
项目类别:
-
资助金额:$52.84万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Equipment supplement to "Training Innate Immunity: A new approach to the treatment of sepsis"
-
批准号:10794766
-
项目类别:
-
资助金额:$13.63万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Equipment Supplement request for a BD LSR Fortessa Flow Cytometer
-
批准号:9275190
-
项目类别:
-
资助金额:$12.74万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Training Innate Immunity: A new approach to the treatment of Sepsis
-
批准号:10669060
-
项目类别:
-
资助金额:$52.67万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7256520
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7811704
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8578744
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8509831
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:9091565
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7086177
-
项目类别:
-
资助金额:$25.8万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8692836
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8112517
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8908015
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:6911533
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:6681426
-
项目类别:
-
资助金额:$26.17万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:6766014
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7786482
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
海外基金